- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07578259
SURA'A Campaign for Stroke Awareness in Primary Health Care Centers (SURA'A)
"Effectiveness of a One-Week Multifaceted SURA'A Consultation-Based Campaign on Stroke Awareness and Intention to Seek Help Among Adults in Primary Health Care Centers
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Aya A Ghayadh, Master
- Numero di telefono: +9647822204528
- Email: ayah.ahmed2106m@conursing.uobaghdad.edu.iq
Backup dei contatti dello studio
- Nome: Sadeq A AL-Fayyadh
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria
Participants will be eligible if they:
Age
- Adults aged ≥18 years residing in Diwaniyah.
- Residence o Living in Diwaniyah communities for at least 6 academic months prior to the study.
Access to Primary Health Centers (PHCs)
- Attending in selected primary health centers where the SURA'A campaign will be implemented.
Cognitive ability
o Able to understand and answer the survey questions in Arabic.
- Consent o Willing to provide informed consent to participate in pre- and post- awareness intervention assessments.
Availability for follow-up
o Agree to participate in both baseline (pre-campaign) and follow-up (post-campaign) assessments.
Exclusion Criteria
Participants will be excluded if they:
- Have a previous confirmed diagnosis of stroke (to avoid bias in baseline awareness).
Severe cognitive impairment
- Have diagnosed dementia, severe mental illness, or cognitive impairment that prevents reliable responses.
Communication barriers
o Cannot communicate in Arabic or has severe hearing/speech impairment that prevents participation.
- Health professionals o Physicians, nurses, paramedics, or students of medical and health colleges (to avoid overestimation of awareness).
Temporary visitors
o Non-residents or individuals visiting Diwaniyah temporarily.
- Refusal or withdrawal o Decline to participate or withdraw at any stage of the study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: SURA'A Consultation-Based Campaign Group
This experimental group will participate in a one-week multifaceted SURA'A consultation-based campaign.
The intervention focuses on increasing stroke awareness and the intention to seek medical help among adults in primary health care centers through structured professional consultations and educational materials.
|
The intervention consists of a one-week multifaceted SURA'A consultation-based campaign. This campaign is designed to increase stroke awareness and the intention to seek help among adults attending Primary Health Care Centers. The multifaceted approach likely includes: Targeted Consultations: Providing direct information to participants regarding stroke symptoms and emergency protocols. Educational Outreach: Utilizing the SURA'A framework-which typically focuses on rapid response (Sura'a meaning "speed" in Arabic)-to emphasize the importance of time-sensitive medical intervention. Community Integration: Implementing the campaign within the primary care setting to reach a diverse adult population during their routine health visits. |
|
Nessun intervento: Routine Health Education Group
Participants in this arm will receive the standard routine health education or conventional care regarding stroke awareness typically provided at the Primary Health Care Centers.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Stroke Action Test (STAT)
Lasso di tempo: Baseline (before the campaign) and 1 week later (immediately after the campaign).
|
The Stroke Action Test (STAT) is a validated tool used to assess the participants' knowledge of stroke symptoms and their intended behavioral response (intention to seek help) when witnessing a stroke.
It consists of multiple scenarios or questions.
Scores are calculated based on correct identified actions, with higher scores indicating better knowledge and more appropriate intended response to stroke symptoms.
|
Baseline (before the campaign) and 1 week later (immediately after the campaign).
|
|
action/intention medical help-seeking sub-scale
Lasso di tempo: Baseline (before the campaign) and 1 week later (immediately after the campaign
|
This sub-scale is a component of the Stroke Action Test (STAT).
It specifically measures the participants' behavioral intentions and their promptness in seeking medical emergency services (e.g., calling an ambulance) when recognizing stroke signs.
It presents various scenarios to evaluate whether the participant would take the correct life-saving action.
|
Baseline (before the campaign) and 1 week later (immediately after the campaign
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 135 (Identificatore di registro: Research Ethical Approval Committee, College of Nursing , University of Baghdad.)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .